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Objective: Premature infants, especially those born less than 1500g, often
exhibit slow overall growth after birth and lack of early nutritional support
may be an important element. We tested the hypothesis that early
administration of amino acids (within the ﬁrst few hours of life) to infants
born at less than 1500g would be associated with fewer infants that were
less than the 10th percentile at 36 weeks post-conceptual age than infants
that received amino acids after the ﬁrst 24h of life.
Study Design: A prospective intervention of early amino-acid (EAA)
supplementation, began before 24h of life, in preterm infants, <1500g,
was compared to a retrospective cohort of preterm infants receiving late
amino-acid (LAA) supplementation, began after 24h of life. The primary
outcome variable was the proportion of infants at less than the 10th
percentile at 36 weeks post-conceptual age.
Result: Fewer infants fell below the 10th percentile (P<0.001) in the
EAA group. Furthermore, infants in the EAA groups had signiﬁcantly
greater weight gains than did the LAA group (P<0.003) after adjusting
for gestational age and time from birth to discharge. In addition, shorter
duration of parenteral nutrition was associated with EAA supplementation
(P<0.001).
Conclusion: A prospective strategy of EAA in preterm infants <1500g
was associated with an improved weight gain, suggesting that nutrition
that included amino acids may be critical during the ﬁrst 24h of life.
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Introduction
The preterm infant misses the last trimester of fetal nutrient
accretion
1,2 and requirement for immediate nutrient delivery that
included amino acids may be essential due to limited glycogen and
fat reserves.
1 Despite this information, signiﬁcant nutrient
deﬁciencies are observed in the neonatal intensive care unit
(NICU)
3 and premature infants are frequently discharged at
weights less than the 10th percentile.
4 Perhaps more concerning
than low discharge weights is the association of poor growth in the
early weeks of hospitalization with abnormal neurodevelopment
and an increased prevalence of cerebral palsy.
5 The goal of early
amino-acid (EAA) supplementation is to provide the preterm infant
with intravenous substrate that promotes protein deposition and
increased lean body mass that more closely approximates fetal
energy production and growth.
6 Recently, it has become evident
that protein delivery of 3gkg
 1 per day beginning on day 1 of life
is safe and is associated with plasma amino-acid concentrations
similar to those of second and third trimester fetuses.
7 Protein
deliveries as minimal as 1.5gkg
 1 per day have resulted in a
neutral/positive nitrogen balance in most infants
8 but maximizing
protein to provide 3gkg
 1 per day beginning immediately after
delivery may further enhance protein deposition that is essential for
early growth.
9 The amount of energy required to support post-
delivery growth rates in premature infants has been demonstrated
to be approximately 3gkg
 1 per day of protein and 90kcalkg
 1
per day.
10,11 In the present study, we tested the hypothesis that early
administration (<24h of life) of parenteral nutrition with EAA
supplementation would be associated with better growth in preterm
infants than in infants in which amino-acid supplementation was
delayed (>24h of life) (late amino acids, LAA).
Methods
The study was conducted in four NICUs contracted by Nationwide
Children’s Hospital in Columbus, OH after institutional review
board approval (IRB no. 05-00411). Informed consent was not
needed as the prospective intervention was a quality improvement
process in the nursery. All data were collected by the same
individual as a part of the Vermont Oxford NIC/Q (Neonatal
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incorporated a PDSA (plan-do-study-act) to implement the change.
These types of cycles to implement changes have been described by
Horbar
12 and in each individual cycle, speciﬁc plans are developed
(Plan), the plans are conducted (Do), the results are evaluated
(Study) and actions are taken based on what has been learned
(Act). In this cycle the plan was to devise a strategy to initiate
parenteral nutrition including amino acids on admission to the
NICUs. The Do was to implement the intervention after education
of all staff and pharmacy, which began in 2005, previously infants
were begun on glucose on day 1 of life and parenteral nutrition
including amino acids was usually started on day 2 of life, at the
discretion of the neonatal team. The study component was to
determine the effect of the intervention, which is encompassed in
the data presented herein. The act component was to adopt the EAA
approach on all infants born less than 1500g at birth.
Subjects
All preterm infants born during 2004 to 2006 and weighed
<1500g at birth, were appropriate for gestational age and survived
the ﬁrst 2 weeks after delivery were included in the study.
Intervention
EAA and LAA supplementation had identical composition that
consisted of TrophAmine (B. Braun, Bethlehem, PA, USA) with
dextrose. The primary variable was the time of administration.
Infants receiving EAA were given 3gkg
 1 per day of amino acids
in glucose administered at 6 to 8mgkg
 1 per min in the NICU
immediately after delivery. Within 24h, glucose load was increased
and lipid emulsion was added to provide 90kcalkg
 1 per day. All
clinical staff and faculty were instructed on the new standard of
care and the goal to start the EAA as the ﬁrst ﬂuids immediately
after delivery. Computer order entry was available for ‘starter TPN’
which was the notation used for EAA, and pharmacy links were
instrumental in expediting the process. Monthly audits revealing
failure to order EAA resulted in updated staff training and
improvement in compliance. No abnormal elevations in blood urea
nitrogen or complications were associated with the new practice.
No infants were withdrawn for intolerance.
Statistical analyses
Descriptive analyses (two group comparisons) were performed for
all the potential covariates and outcome measures and results are
provided in Table 1. A generalized linear model was used to
compare the mean weight gain between LAA (birth year 2004) and
EAA (birth years 2005 and 2006) groups. Weight gain was
computed as the difference between the weight at discharge and
birth weight. Because greater weight gains could be a consequence
of longer hospitalization, gestational age and time from birth to
discharge were included in the model as a covariates and the
weight gain was adjusted accordingly. Gestational age was included
in the ﬁnal model to control for differences in gestational ages at
birth even though the variable ‘time from birth to discharge’ was
included in the ﬁnal model. High positive correlations were
anticipated between age at discharge and weight gain. A sensitivity
analysis using the number of infants in the 10th percentile of the
infant growth chart by age and amino-acid supplementation data
was performed. w
2-Tests and one-way analysis of variance were
used for these sensitivity analyses.
Results
In the years 2005 and 2006, 151 and 157 infants received EAA,
respectively. These 308 infants were compared to 132 preterm
infants from 2004 that did not receive the EAA supplementation.
Table 1 shows the descriptive statistics, P-values and conﬁdence
intervals (CIs) for the unadjusted means of several variables,
including the outcome measures. The unadjusted means for birth
weight were marginally signiﬁcantly different between the two
groups (P¼0.059; Table 1), with lower birth weight infants in the
EAA group. Incidences of intraventricular hemorrhage (IVH),
bacteremia, necrotizing enterocolitis (NEC) were not signiﬁcantly
different among all groups studied (Table 2). A marginally greater
Table 1 Demographics and weight data analyzed by LAA vs EAA
LAA, mean (s.e.),
N¼132
EAA, mean (s.e.),
N¼308
Difference
(EAA LAA)
P-value 95% CI
Birth weight (g) 1202.2 (20.1) 1157.9 (13.0)  45.30 0.059 ( 92.40, 1.73)
Gestational age (weeks) 29.4 (0.19) 29.06 (0.13)  0.38 0.106 ( 0.85, 0.08)
Discharge weight (g) 2242.8 (33.4) 2342.8 (24.3) 100.04 0.016
a (18.69, 181.39)
Gestational age at discharge (weeks) 36.48 (0.17) 36.73 (0.13) 0.25 0.241 ( 0.17, 0.68)
Net time (weeks) 7.04 (0.23) 7.68 (0.16) 0.64 0.025
a (0.08, 1.19)
Weight gain 1040.6 (38.8) 1186.0 (26.8) 145.379 0.003
a (50.76, 239.99)
Birth weight <1000g (%) 20.45 26.62 6.17 0.153 ( 0.02, 0.15)
Abbreviations: EAA, early amino acid; LAA, late amino acid.
aFor statistical analyses see Methods, P<0.027 was needed for signiﬁcance.
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moderate BPD (supplemental oxygen at 36 weeks gestation), was
observed in the EAA group (P¼0.05). The infants in the EAA
groups achieved full enteral feeding sooner (>100mlkg
 1 per day
of enteral feeds, no parenteral nutrition) with a mean 7.7 days in
2005 and 8.3 days in 2006 compared to 9.9 days in 2004
(P<0.039), despite similar incidences of morbidities.
Time from birth to discharge was positively associated with
weight gain (P<0.001). Although gestational age was not a
signiﬁcant predictor (P¼0.309), group (EAA or LAA) was a
signiﬁcant predictor of weight gain (P¼0.034). The difference in
the adjusted mean weight gain between the EAA and the LAA
groups was 51.28g (95% CI 3.76, 98.81) resulting in adjusted
weight gains of 1158 vs 1106g. Weights at birth and discharge were
plotted on the Fenton growth chart (Figure 1). Sensitivity analyses
of weights at 36 weeks corrected gestational age (CGA) indicated
fewer infants falling below the 10th percentile in the EAA groups
(23.7%) than in the LAA group (41.7%) (P<0.0001; 95% CI
 27.6,  8.30; Figure 1).
z-score calculations were evaluated for both groups. The
decrement in falling away from the curve was less in EAA than in
the LAA group; the z-scores at birth were  0.41 (34th percentile)
and  0.26 (40th percentile) and progressed to  1.03 (15th
percentile) and  1.27 (10th percentile) at 36 weeks CGA,
respectively.
13 Most interesting was the result that parenteral
nutrition duration was affected by how early the PN was started. PN
start times of <24h, 24 to 48h or >48h were associated with
durations of 13, 18 and 23 days, respectively (P<0.001).
Discussion
Early administration of amino acids has been shown to be safe and
promotes nitrogen balance and glucose tolerance in preterm
infants.
7,8,14 Our hypothesis was that this nutritional intervention
would be associated with better weight gain and decrease growth
failure (deﬁned by being less than the 10th percentile at discharge)
traditionally seen in NICU graduates.
Better weight gain is a bit difﬁcult to interpret because longer
hospitalizations should be associated with higher weight gains than
shorter hospitalizations and because the duration of hospitalization
is not necessarily included in the analysis. However, we adjusted for
this statistically and the data adjusted for length of hospitalization
remained signiﬁcant. Furthermore, the z-scores, which are a
measure of the difference from the mean, had a statistically larger
decrement in the LAA group than in the EAA group, resulting in
fewer infants that were less than the 10th percentile at 36 weeks
PCA in the EAA group than in the LAA group. Interestingly, a
greater incidence of BPD was observed in the EAA group that,
because BPD is associated with slower weight gains, should have
blunted the weight gains in our EAA group.
Table 2 Morbidities between the LAA and EAA groups
Counts (%) LAA, mean (s.e.),
N¼132
EAA, mean (s.e.),
N¼308
Difference
(EAA LAA)
P-value 95% CI
Bacteremia 15 (11.4%) 23 (7.5%)  3.9% 0.215 ( 10.0, 2.3)
NEC 7 (5.30%) 22 (7.14%) 1.83% 0.451 ( 2.9, 6.6)
IVH 32 (24.2%) 65 (21.1%)  3.1% 0.475 ( 11.75, 5.45)
PDA 36 (27.27%) 100 (32.47%) 5.2% 0.270 ( 4.02, 14.41)
BPD 25 (18.93%) 84 (27.27%) 8.3% 0.050 (0.00, 16.67)
Abbreviations: BPD, bronchopulmonary dysplasia; EAA, early amino acid; IVH, intraventricular hemorrhage; LAA, late amino acid; NEC, necrotizing enterocolitis; PDA, patent ductus
arteriosus.
Figure 1 Percentiles of mean weight at birth and discharge for the late amino
acid (LAA, red dot) and early amino acid (EAA, ‘x’) were plotted. Discharge weight
was signiﬁcantly greater in the EAA group (P¼0.03). The infants in the EAA
groups had signiﬁcantly less growth failure at discharge as deﬁned by number
<10th percentile. The z-scores
13 at 36 weeks were  1.27 in the LAA and  1.03
in the EAA, respectively, and the decrement in z-score was 0.62 in the EAA group
and 1.01 in the LAA group from birth to discharge. Figure reprinted with
permission from Tanis Fenton.
18
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delivery with weight gain. The ﬁrst study was initially powered for
examination of glutamine supplementation and therefore weight
gain was a secondary analysis of their data.
15 They did ﬁnd that
early provision of 3gkg
 1 per day of amino acids within 5 days of
birth improved weight at 36 weeks compared to preterm infants
that received 3gkg
 1 per day after 5 days. However, the groups
remained in low weight percentiles with 82 and 95% less than the
10th percentile, respectively, according to the Alexander et al.
chart.
16 These data are consistent with our data but the cutoff of 5
days was far more conservative than the intervention used in this
study. The second study was designed to evaluate preterm infant
weight gains at 28 days after amino-acid supplementation and
infants were randomly assigned at 3.5 and 2.5gkg
 1 per day,
respectively.
17 The inclusion criteria were preterm infants 23 to 29
weeks and 6 days gestation in a multicenter (n¼11), randomized
controlled trial to began amino-acid support with 1gkg
 1 per day
and advanced by 0.5 to 1gkg
 1 per day to ﬁnal intake of 3.5 and
2.5gkg
 1 per day protein, respectively.
17 Filter paper spots (whole
blood) were obtained to measure amino-acid levels. The higher
intake of protein resulted in greater blood amino-acid levels but no
difference was observed in weight gain at 28 days (12.9 vs 11.4g,
respectively).
17 In our study, 3gkg
 1 per day of amino acids were
administered as soon as possible after delivery (mean of 7.5h by
2006), which may explain our difference in ﬁnal weight outcome.
The Fenton curve was recently adopted by the Vermont Oxford
Quality Improvement Collaborative on Nutrition to be the growth
chart appropriate for use in the preterm infant population
(Figure 1). Our data demonstrated fewer infants falling below the
10th percentile for weight from the Fenton curves
18 compared to
the previous publication by Poindexter et al.
15 A recent study
reported by the NICHD indicated that 90% of infants <1000g fell
below fetal growth curve estimates
19 at 36 weeks CGA. The mean
weight cutoff for the 10th percentile used by this groups was a fetal
weight curve by Alexander et al.
16 which has a 10th percentile
mean of 2354g for 36 weeks whereas the Fenton curve that we
used in our study has the mean weight cutoff for the 10th
percentile at 2237g. Had we used the Alexander reference growth
data, only 64, 40 and 30% of our infants would fall below that 10th
percentile mean in 2004, 2005 and 2006, respectively, all of which
are improvements from previous observations reported in the
literature.
Another interesting observation was that the infants in the EAA
groups had shorter durations of TPN administration and achieved
full enteral feeding earlier despite being smaller and younger. Milk
initiation, method, advancement and type can inﬂuence feeding
tolerance.
20–22 Our written neonatal nutrition guidelines
emphasizing early (by day 4 of life), trophic (<20mlkg
 1 per
day) and bolus feeding were followed throughout the study time
period. Our institution uses tolerated feeds of 120mlkg
 1 per day
as the criteria for ceasing parenteral nutrition such that duration
of parenteral nutrition is inversely related to the time for tolerance
of enteral nutrition. Human milk and formula feeding were similar
throughout all years. Because the composition of the parenteral
amino-acid mixture and the enteral feeding protocols were
identical during the time frame included in these studies, these
ﬁnding raise the provocative question whether EAA improves
gastrointestinal motility and reduces feeding intolerance. We
postulate that EAA may result in earlier attainment of enteral feeds
by improving gastrointestinal motility perhaps through neural or
humeral responses. The earlier transition may have had an overall
effect on growth by providing enteral stimulation and thus earlier
protein synthesis. However, this study was not designed or powered
to address this question.
On the basis of the z-scores calculated from the Fenton curve,
the growth rates of the infants in this study given EAA were not
abnormally accelerated whereas the group receiving LAA actually
had a higher incidence of growth retardation. Slower weight gain
as deﬁned by velocities has been correlated to lower developmental
index scores and increased risk of cerebral palsy
5 and emphasizes
the importance of early interventions to promote growth. In
contrast, excessive weight gain as deﬁned by velocities exceeding
growth parallel to percentile lines can be a concern for the
development of later metabolic diseases.
23 The biological effect of
the small difference observed in weight gain between the EAA and
LAA groups is unknown, but may be important because of the
association between weight gain velocities and neurodevelopmental
outcomes.
Despite less extrauterine growth failure in the EAA groups, all
groups had fallen off their own intrauterine trajectory and weighed
less at discharge than they would have had they stayed in their
intrauterine environment. This fall off of growth, in spite of our
interventions, may mean that our preterm infants were still protein
limited even with the provision of 3gkg
 1 per day of amino acids.
One study evaluating daily enteral intakes approximating 3.2 to
3.5gkg
 1 per day protein (500 to 550mgkg
 1 per day nitrogen)
was able to more closely mimic intrauterine estimations for
nitrogen retention.
24 With more immature infants surviving and
the established relationship between amino-acid supplementation
and extrauterine growth, future studies evaluating greater
supplementation levels immediately after delivery such as 3.5 to
4gkg
 1 are appropriate.
One acknowledged limitation to our study was the retrospective
component of the comparisons. The optimal approach to
determine the effects of EAA intervention would be a randomized
controlled approach, however, our institution felt that the evidence
for the beneﬁts of EAA supplementation was too compelling to
conduct such a trial for LAA supplementation after 2004. A second
limitation was the lack of assessments of protein kinetics or body
composition. In the clinical setting these are often difﬁcult and at
the current time, weight can be used as a good measure of
nutritional adequacy.
25 In addition, more sophisticated measures of
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composition are needed to deﬁne mechanisms of nutrient intake
and growth in the preterm infant.
In summary, we found an association between EAA
administration and less growth failure at term than in infants
given amino acids later. Additional studies to determine the effects
of EAA administration on protein kinetics and evaluation of even
more aggressive nutritional interventions are warranted.
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